United States Pediatric Vaccines Market, Doses, Immunization Cases & Forecast

1
(No Transcript)
2
Table of Contents

• Executive Summary
• United States Pediatric Vaccines Market
  Forecast
• United States Pediatric Vaccines Market Share
  Forecast
• 4. United States Pediatric Vaccines Cases,
  Doses, Immunization Coverage, Market Forecast
• 4.1 United States Measles, Mumps Rubella
  (MMR) Vaccines Forecast
• 4.1.1 Number of Measles, Mumps Rubella (MMR)
  Cases
• 4.1.2 Number of Measles, Mumps Rubella (MMR)
  Vaccines Doses

3
Continue (www.renub.com)
4.1.3 Measles, Mumps Rubella (MMR) Number of
Children Being Vaccinated 4.1.4 Market Size of
Measles, Mumps Rubella (MMR) Vaccines 4.2
United States Haemophilus Influenzae Type B
(HIB) Vaccines Forecast 4.2.1 Number of
Haemophilus Influenzae Type B (HIB) Vaccines
Doses 4.2.2 Haemophilus Influenzae Type B (HIB)
Number of Children Being Vaccinated 4.2.3 Market
Size of Haemophilus Influenzae Type B (HIB)
Vaccines
4
Continue (www.renub.com)
4.3 United States Polio Vaccines
Forecast 4.3.1 Number of Polio Cases 4.3.2
Number of Polio Vaccines Doses 4.3.3 Polio
Vaccines Number of Children Being
Vaccinated 4.3.4 Market Size of Polio
Vaccines 4.4 United States Diphtheria, Tetanus
Pertussis (DTap) Vaccines Forecast 4.4.1
Number of Diphtheria, Tetanus Pertussis (DTaP)
Cases 4.4.2 Number of Diphtheria, Tetanus
Pertussis (DTaP) Vaccines Doses
5
Continue (www.renub.com)
4.4.3 Diphtheria, Tetanus Pertusis (DTaP)
Number of Children Being Vaccinated 4.4.4 Market
Size of Diphtheria, Tetanus Pertussis (DTaP)
Vaccines 4.5 United States Pneumococcal
Vaccines Forecast 4.5.1 Number of Pneumococcal
Vaccines Doses 4.5.2 Pneumococcal Number of
Children Being Vaccinated 4.5.3 Market Size of
Pneumococcal Vaccines 4.6 United States
Rotavirus Vaccines Forecast 4.6.1 Number of
Rotavirus Vaccines Doses
6
Continue (www.renub.com)

• 4.6.2 Rotavirus Number of Children Being
  Vaccinated
• 4.6.3 Market Size of Rotavirus Vaccine
• 4.7 United States Hepatitis B Pediatric
  Vaccines Forecast
• 4.7.1 Number of Hepatitis B Pediatric Vaccines
  Doses
• 4.7.2 Hepatitis B Pediatric Number of Children
  Being Vaccinated
• 4.7.3 Market Size of Hepatitis B Pediatric
  Vaccines

7
Continue (www.renub.com)
4.8 United States Hepatitis A Pediatric
Vaccines Forecast 4.8.1 Number of Hepatitis A
Pediatric Vaccines Doses 4.8.2 Hepatitis A
Pediatric Number of Children Being Vaccinated
Forecast 4.8.3 Market Size of Hepatitis A
Pediatric Vaccines 4.9 United States Varicella
/ Chicken Pox Vaccines Forecast 4.9.1 Number
of Varicella / Chicken Pox Vaccines Doses 4.9.2
Varicella/Chicken Pox Number of Children Being
Vaccinated 4.9.3 Market Size of Varicella/Chicken
Pox Vaccines
8
Continue (www.renub.com)
4.10 United States Influenza Pediatric
Vaccines Forecast 4.10.1 Number of Influenza
Pediatric Vaccines Doses 4.10.2 Influenza
Pediatric Vaccines Number of Children Being
Vaccinated 4.10.3 Market Size of Influenza
Pediatric Vaccines 5. Growth Drivers of United
States Pediatric Vaccines Market 5.1 Increase
Immunization Rates Reduce Preventable
Infectious Diseases 5.2 Increasing Vaccine
Availability in United States 5.3 The Vaccine
Safety Data link Project
9
Continue (www.renub.com)
5.4 The Vaccine Injury Compensation Program 5.5
Transforming of Vaccine Technologies 5.6
Continuous Focus on Effective Communication
Strategies 6. Challenges of United States
Pediatric Vaccines Market 6.1 Impediment in
Pediatric Vaccine Research Development 6.2
Barriers to New Entrants in the Pediatric
Vaccines Market 6.3 Hurdles to Optimal use of
Licensed Vaccines 6.3.1 Technical
Obstacles 6.3.2 Economic obstacles
10
Continue (www.renub.com)
6.3.3 Cultural Obstacles 6.4 Complexity of
Vaccine Development Approval System Thwarts
Product Development 6.4.1 Legal Obstacles 6.4.2
General Technical Barriers 6.4.3 Economic
Barriers 6.4.4 Regulatory Barriers 6.5
Shortening the Timeline for Vaccine Development
11
Continue (www.renub.com)

• 6.6 Refusal / Resistance to Vaccination
• 6.6.1 Vaccine Adverse Event Reporting System
• 6.7 Vaccine Shortages and Delays
• 6.8 Emerging Issues in Immunization and
  Infectious Diseases in United States

12
Data Sources

• This report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and inhouse analysis by Renub
  Research team of industry experts.
• Primary sources include industry surveys and
  telephone interviews with industry experts.
• Secondary sources information and data has been
  collected from various printable and
  nonprintable sources like search engines, News
  websites, Government Websites, Trade Journals,
  White papers, Government Agencies, Magazines,
  Newspapers, Trade associations, Books, Industry
  Portals, Industry Associations and access to more
  than 500 paid databases.

13
Order Form
Scan and e-mail this page to info_at_renub.com,
alternatively one can also write the Contact
Information in an e-mail and mail it.
Questions? Please call
1-678-302-0700 (USA)
91-120-421-9822 (India), ,91-120-424-9780
or mail to info_at_renub.com
14
Format
Report Title United States Pediatric Vaccines
Market, Doses, Immunization (Vaccinated), Cases
Forecast
For More Details
http//www.renub.com/report/united-states-pediatri
c-vaccines-market-doses-immunization-vaccinated-ca
ses-forecast-165
Single User (Email from Publisher) Hard Copy (Mail Delivery) CD Rom (Mail Delivery) Global Site License (Multiple User License)
US 1,100 US 1,200 US 1,200 US 1,900
15
For ordering this report Three easy ways to
place your order

• 1) Order online by Credit Card (Visa, MasterCard,
  etc.)
• http//www.renub.com/buyreport/165-1630
• 2) Order by Wire Transfer
• http//www.renub.com/report/wiretransfer.aspx?id1
  65pid1630
• To pay by Wire Transfer, please, fill in your
  contact details in the form below

16
Bank Details

• Account Name Renub Research
• A/C No. 109102000023296
• Name of Bank IDBI Bank Ltd.
• Swift Code IBKLINBB010
• Bank Address 4th Floor
• Indian Red Cross Building
• 1 Red Cross Road
• Opposite Parliament Street
• New Delhi 110001
• India

17
Contact Information
  First Name Last
Name Email Job Title Company
Address City Postal/Zip Code Country
Phone Mobile Fax Report Format Your
message
18
Order by Check

• Please post the check accompanied by this form,
  to
• Company Address Renub Research
• 1st Floor,
• C-86, Sector-10
• Noida - 201301
• Uttar Pradesh
• India
• Phone
  91-120-421-9822, 424-9780
• For free Sample copy report or to view any of our
  sample work please contact us at info_at_renub.com
  or call 91-120-421-9822 (India), 1-678-302-0700
  (USA)